FDA to accelerate Pfizer COVID vaccine approval - report

Friday, 30. July 2021 20:53

Under pressure, the United States Food and Drug Administration (FDA) is planning to expedite the process to grant the Pfizer Inc./BioNTech SE vaccine full approval, STAT reported on Friday.

The regulator will reportedly deprioritize meetings with drug sponsors and plant inspections in an effort to complete the process faster. Authorities and health experts believe that the full approval will help convince the unvaccinated to get their shots and give businesses a stronger legal foundation to impose vaccine mandates, STAT said.

"We have taken an all-hands-on-deck approach, including identifying additional resources such as personnel and technological resources from across the agency and opportunities to reprioritize other activities, in order to complete our review to help combat this pandemic surge," an FDA spokesperson told the news organization.

Related Links: BioNTech SEPfizer Inc.
Author:
Breaking the News / MD